ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataShowing 20 of 12219 recruiting trials
A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
🏥 Shanghai Jiaolian Drug Research and Development Co., Ltd📍 17 sites📅 Started Jul 2024View details ↗
Dupilumab in the Treatment of Pediatric Alopecia Areata
👨⚕️ Emma Guttman-Yassky, MD, PhD, Icahn School of Medicine at Mount Sinai📍 5 sites📅 Started Jul 2024View details ↗
Triheptanoin for Children With Primary-Specific Pyruvate Dehydrogenase Complex (PDC) Deficiency
👨⚕️ Jirair Bedoyan, MD, PhD, UPMC Children's Hospital of Pittsburgh📍 1 site📅 Started Jul 2024View details ↗
Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases
👨⚕️ Hye Ryun Kim, Yonsei University Health system, Severance Hospital📍 1 site📅 Started Jul 2024View details ↗
Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers
Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab
Zopa Retreatment and Vector Shedding in Adults With RRP
Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
Combination of Orelabrutinib and Obinutuzumab in Untreated Marginal Zone Lymphomas
DapagliFLOzin in Renal AL Amyloidosis (FLORAL)
👨⚕️ Jeffrey Zonder, M.D., Barbara Ann Karmanos Cancer Institute📍 1 site📅 Started Jul 2024View details ↗
A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
RecruitingNCT06683690 ↗
TGF β 1 Expression Related Gene Polymorphism
👨⚕️ Moustafa Adam Ali El Taieb, Professor, Dermatology, Venereology and Andrology. Faculty of Medicine, Aswan University📍 1 site📅 Started Jul 2024View details ↗
Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells
Durvalumab With Gemcitabine and Cisplatin for the Treatment of High-Risk Resectable Liver Cancer Before Surgery
👨⚕️ Hop S Tran Cao, University of Texas MD Anderson Cancer Center LAO📍 58 sites📅 Started Jul 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →